Investors are undervaluing promising drug candidates on the horizon for the two pharma giants, write Yale SOM’s Jeffrey ...

Aishwarya Solanki ’25 reflects on her time studying with finance industry pioneers and crafting private equity proposals as a ...

According to Prof. Jeffrey Sonnenfeld and co-author Steven Tian, the college and university presidents who attended the Yale ...

MBA Two-year program for leaders in all industries. MBA for Executives Rigorous executive MBA for accomplished professionals. Master of Advanced Management MBA graduates of top business schools around ...

Yale SOM provides a small number of partial scholarships to exceptional candidates for the MBA for Executives program. Recipients of these highly selective awards have a demonstrated track record of ...

From application tips to student panels, this selection of previously recorded events offers insights into Yale School of Management’s unique curriculum and collaborative culture.

About Health & Veritas Howard Forman and Harlan Krumholz, two Yale physician-professors, discuss the latest news and ideas in healthcare and seek out the truth amid the noise. Produced with the Yale ...

Yale School of Management Edward P. Evans Hall 165 Whitney Avenue New Haven, CT 06511-3729 ...

Jeffrey Sonnenfeld discusses a prolonged stretch of share underperformance for both Pfizer and Merck even with paradoxically good revenues in FORTUNE ...

Daniel Weiss ’85, an art historian and the former president and CEO of the Metropolitan Museum of Art, discusses the complexities, joys, and challenges of leading mission-driven organizations.‌ Art is ...

Class I 9:00 a.m.-12:00 p.m. Class III 8:00 a.m.-11:00 a.m. Lunch 12:00 p.m.-1:00 p.m. Lunch 11:00 a.m.-12:00p.m. Colloquium 1:00 p.m.-2:00 p.m. Class IV 12:00 p.m.-3 ...